Published In
Archives of Rheumatology
Volume 21 · Issue 2
Pages: 060-066
History
Published Online: June 30, 2006
This work is licensed under a Creative Commons Attribution 4.0 International License.
Hatice Bodur
Ankara Numune Eğitim ve Araştırma Hastanesi, Fizik Tedavi ve Rehabilitasyon Kliniği, Ankara, Türkiye
Hatice Bodur. (2006). Methotrexate and Leflunomide in the Treatment of Rheumatoid Arthritis. Archives of Rheumatology, 21(2), 060–066. Retrieved from https://archivesofrheumatology.org/index.php/pub/article/view/195
Full Text
PDF (Türkçe)
PDF (Türkçe)
Abstract
The treatment of rheumatoid arthritis has changed in the last ten years. Methotrexate is an antimetabolite drug and commonly used as the first disease modifying antirheumatic drug (DMARD). Its clinical efficacy and safety profile has been documented and it slows the development of radiological erosions. Leflunomide is also an antimetabolite drug and relatively new. In this review the efficacy, safety, mono and combination therapy of these drugs have been discussed. (Rheumatism 2006; 21: 60-6)
Similar Articles
Article Info
Published In
Journal
Archives of Rheumatology
Volume / Issue
Volume 21 · Issue 2
Pages
060-066
History
Published Online
June 30, 2006
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Affiliations
Hatice Bodur
Ankara Numune Eğitim ve Araştırma Hastanesi, Fizik Tedavi ve Rehabilitasyon Kliniği, Ankara, Türkiye
Cite this Article
Hatice Bodur. (2006). Methotrexate and Leflunomide in the Treatment of Rheumatoid Arthritis. Archives of Rheumatology, 21(2), 060–066. Retrieved from https://archivesofrheumatology.org/index.php/pub/article/view/195
Outlines